Teva Pharmaceutical Industries Ltd - Company Profile

Powered by

All the data and insights you need on Teva Pharmaceutical Industries Ltd in one report.

  • Save hours of research time and resources with
    our up-to-date Teva Pharmaceutical Industries Ltd Strategy Report

  • Understand Teva Pharmaceutical Industries Ltd position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Back to companies

Teva Pharmaceutical Industries Ltd: Overview

Teva Pharmaceutical Industries Ltd (Teva) discovers, develops, manufactures, and commercializes generic and specialty medicines. The company provides specialty medicines to treat disorders of the central nervous system (CNS), cancer, respiratory, dermatology, women’s health, and other disease conditions. It offers generic medicines in a range of dosage forms including capsules, tablets, injectables, liquids, inhalants, creams, and ointments. Teva also provides over-the-counter (OTC) products, besides active pharmaceutical ingredients (APIs). It also focuses on developing generic drugs. The company conducts its worldwide operations through a network of subsidiaries in regions such as North America, Europe, and International Markets. Teva is headquartered in Tel Aviv, Israel.

Gain a 360-degree view of Teva Pharmaceutical Industries Ltd and make more informed decisions for your business Gain a 360-degree view of Teva Pharmaceutical Industries Ltd and make more informed decisions for your business Find out more
Headquarters Israel

Address 124 Dvora HaNevi'a St., Tel Aviv, 6944020


Telephone 972 3 9148213

No of Employees 35,001

Industry Pharmaceuticals and Healthcare

Ticker Symbol & Exchange TEVA (TLV)

Revenue (2023) $15.8B 6.2% (2023 vs 2022)

EPS XYZ

Net Income (2023) XYZ 77.1% (2023 vs 2022)

Market Cap* $14.5B

Net Profit Margin (2023) XYZ 78.5% (2023 vs 2022)

* As of and is in US$
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Find out more

Teva Pharmaceutical Industries Ltd premium industry data and analytics

1,600+

Marketed Drugs

Understand Teva Pharmaceutical Industries Ltd’s commercialized product portfolio to stay one step ahead of the market.

1,500+

Clinical Trials

Determine Teva Pharmaceutical Industries Ltd go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

240+

Pipeline Drugs

Identify which of Teva Pharmaceutical Industries Ltd’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

240+

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

220+

Lead Sheet

Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for Teva Pharmaceutical Industries Ltd’s relevant decision makers and contact details.

190+

Catalyst Calendar

Proactively evaluate Teva Pharmaceutical Industries Ltd’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

30+

Regulatory Milestones

Track drug and patent expiries along with geographies impacted.

20+

Sales & Consensus Forecasts

Understand the current and future drug revenue for Teva Pharmaceutical Industries Ltd and assess market opportunity for new entrants with patient population 8-year forecasts.

3

IT Services Contracts

Improve competitive bidding with insights into all publicly disclosed IT services contracts for Teva Pharmaceutical Industries Ltd (including IT outsourcing, business process outsourcing, systems integration & consulting and more).

Products and Services

Products Brands
Innovative Medicines: Apriso
Central Nervous System NuvaRing
Respiratory AndroGel
XYZ XYZ
XYZ XYZ
XYZ XYZ
Understand Teva Pharmaceutical Industries Ltd portfolio and identify potential areas for collaboration Understand Teva Pharmaceutical Industries Ltd portfolio and identify potential areas for collaboration Find out more

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2023 Contracts/Agreements In December, the company and Biolojic Design Ltd entered into a licensing agreement to develop an innovative antibody-based therapy for the treatment of Atopic Dermatitis and Asthma.
2023 Contracts/Agreements In October, Teva Pharmaceuticals and Sanofi announced a collaboration to co-develop and co-commercialize asset TEV'574.
2023 Contracts/Agreements In June, Teva Pharmaceuticals entered into an agreement with the Attorney General of Kentucky to settle the state’s price-fixing claims against Teva.
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Find out more
Image for loader

Competitor Comparison

Key Parameters Teva Pharmaceutical Industries Ltd Merck & Co Inc Pfizer Inc AstraZeneca Plc Bristol-Myers Squibb Co
Headquarters Israel United States of America United States of America United Kingdom United States of America
City Tel Aviv Kenilworth New York Cambridge Princeton
State/Province Tel Aviv New Jersey New York England New Jersey
No. of Employees 35,001 69,000 88,000 89,900 34,100
Entity Type Public Public Public Public Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Find out more
Executives
Name Position Board Since Age
Sol J. Barer, Ph.D. Chairman Executive Board 2017 75
Richard Francis Director; Chief Executive Officer; President Executive Board 2023 -
Eli Kalif Chief Financial Officer; Executive Vice President Senior Management 2019 50
David M. Stark Chief Legal Officer; Executive Vice President Senior Management 2016 54
Eric A. Hughes, MD Chief Medical Officer; Executive Vice President - Global R&D Senior Management 2022 -
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Gain insight into Teva Pharmaceutical Industries Ltd key executives to enhance your sales strategy Gain insight into Teva Pharmaceutical Industries Ltd key executives to enhance your sales strategy Find out more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward